Wesfarmersâ $687m move on API makes sense The companyâs move into pharmaceutical distribution through the takeover of Australian Pharmaceutical Industries is a slap in the face for those who think conglomerates are not suited to delivering growth. Updated Save Share As a member of Pricelineâs Sister Club loyalty program, Wesfarmers chief executive Rob Scott is familiar with the business model underpinning his latest takeover target, Australian Pharmaceutical Industries. He says his membership of the Priceline loyalty program is in keeping with the philosophy at Wesfarmers that all senior executives must have first-hand understanding of the businesses they own and operate.